- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Chronic plaque psoriasis
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 886KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 47KB)
Biologics for the treatment of chronic plaque psoriasis: Cost-effectiveness review – July 2020
Biologics for the treatment of chronic plaque psoriasis: Cost-effectiveness review
Last updated
9 July 2025